These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 35676661

  • 21. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
    Wang X, Jin Q, Wang X, Chen W, Cai Z.
    Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
    Huang Q, Hou S, Zhu X, Liu S.
    World J Surg Oncol; 2020 Feb 03; 18(1):29. PubMed ID: 32013999
    [Abstract] [Full Text] [Related]

  • 23. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
    Yang J, Qin L, Zhou S, Li J, Tu Y, Mo M, Liu X, Huang J, Qin X, Jiao A, Wei W, Yang P.
    J Ethnopharmacol; 2024 Apr 06; 323():117667. PubMed ID: 38159821
    [Abstract] [Full Text] [Related]

  • 24. Capn4 regulates Snail to promote the epithelial-mesenchymal transition of nasopharyngeal carcinoma by mediating the transcriptional activity of claudin-11.
    Yang F, Wang F, Gao ZS, Quang GQ, Hu HB, Zheng M.
    Kaohsiung J Med Sci; 2023 Feb 06; 39(2):134-144. PubMed ID: 36354184
    [Abstract] [Full Text] [Related]

  • 25. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P, Lu X, Shi Z, Li X, Zhang Y, Zhao S, Liu H.
    Gene; 2019 Aug 20; 710():103-113. PubMed ID: 31158447
    [Abstract] [Full Text] [Related]

  • 26. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling.
    Pan S, Liang S, Wang X.
    Life Sci; 2021 Aug 01; 278():119581. PubMed ID: 33961854
    [Abstract] [Full Text] [Related]

  • 27. Squalene epoxidase-induced cholesteryl ester accumulation promotes nasopharyngeal carcinoma development by activating PI3K/AKT signaling.
    Li L, Zhang Q, Wang X, Li Y, Xie H, Chen X.
    Cancer Sci; 2020 Jul 01; 111(7):2275-2283. PubMed ID: 32314495
    [Abstract] [Full Text] [Related]

  • 28. FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway.
    Chen E, Huang J, Chen M, Wu J, Ouyang P, Wang X, Shi D, Liu Z, Zhu W, Sun H, Yang S, Zhang B, Deng W, Qiu H, Xie F.
    J Transl Med; 2023 Feb 22; 21(1):134. PubMed ID: 36814284
    [Abstract] [Full Text] [Related]

  • 29. Upregulation of Long Noncoding RNA_GAS5 Suppresses Cell Proliferation and Metastasis in Laryngeal Cancer via Regulating PI3K/AKT/mTOR Signaling Pathway.
    Liu W, Zhan J, Zhong R, Li R, Sheng X, Xu M, Lu Z, Zhang S.
    Technol Cancer Res Treat; 2021 Feb 22; 20():1533033821990074. PubMed ID: 33641529
    [Abstract] [Full Text] [Related]

  • 30. Capsaicin Induces Autophagy and Apoptosis in Human Nasopharyngeal Carcinoma Cells by Downregulating the PI3K/AKT/mTOR Pathway.
    Lin YT, Wang HC, Hsu YC, Cho CL, Yang MY, Chien CY.
    Int J Mol Sci; 2017 Jun 23; 18(7):. PubMed ID: 28644386
    [Abstract] [Full Text] [Related]

  • 31. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
    Wang MH, Sun R, Zhou XM, Zhang MY, Lu JB, Yang Y, Zeng LS, Yang XZ, Shi L, Xiao RW, Wang HY, Mai SJ.
    Cell Death Dis; 2018 Jan 05; 9(1):2. PubMed ID: 29305578
    [Abstract] [Full Text] [Related]

  • 32. Homeobox B2 promotes malignant behavior and contributes to the radioresistance of nasopharyngeal carcinoma by regulating forkhead box protein O1.
    Chen J, Mao M, Ma Z, Liu J, Jiang M, Chen G, Xu Y.
    Int J Med Sci; 2024 Jan 05; 21(5):837-847. PubMed ID: 38617001
    [Abstract] [Full Text] [Related]

  • 33. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
    Xuefang Z, Ruinian Z, Liji J, Chun Z, Qiaolan Z, Jun J, Yuming C, Junrong H.
    Technol Cancer Res Treat; 2020 Jan 05; 19():1533033819892251. PubMed ID: 31984860
    [Abstract] [Full Text] [Related]

  • 34. LINC00324 suppresses apoptosis and autophagy in nasopharyngeal carcinoma through upregulation of PAD4 and activation of the PI3K/AKT signaling pathway.
    Chen H, Wei L, Luo M, Wang X, Zhu C, Huang H, Liu X, Lu H, Zhong Y.
    Cell Biol Toxicol; 2022 Dec 05; 38(6):995-1011. PubMed ID: 34322788
    [Abstract] [Full Text] [Related]

  • 35. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
    Yang Y, Li Q, Guo L.
    Mol Med Rep; 2018 Jun 05; 17(6):8244-8252. PubMed ID: 29693120
    [Abstract] [Full Text] [Related]

  • 36. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
    Peng H, Gong PG, Li JB, Cai LM, Yang L, Liu YY, Yao KT, Li X.
    J Transl Med; 2016 May 11; 14(1):131. PubMed ID: 27170279
    [Abstract] [Full Text] [Related]

  • 37. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals.
    Zhang W, Zhang Y, Xi S.
    Artif Cells Nanomed Biotechnol; 2019 Dec 11; 47(1):3043-3052. PubMed ID: 31334669
    [Abstract] [Full Text] [Related]

  • 38. Relationship of PI3K-Akt/mTOR/AMPK signaling pathway genetic mutation with efficacy and prognosis in nasopharyngeal carcinoma.
    Chen Y, He Q, Ma H, Zhang L, Liu F, Han Y.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb 28; 47(2):165-173. PubMed ID: 35545406
    [Abstract] [Full Text] [Related]

  • 39. MiR-3612 targeting THBS1 suppresses nasopharyngeal carcinoma progression by PI3K/AKT signaling pathway.
    Zhang W, Zhang Q, Cui Q, Xu Y.
    Hum Exp Toxicol; 2023 Feb 28; 42():9603271221150248. PubMed ID: 36607163
    [Abstract] [Full Text] [Related]

  • 40. Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway.
    Guo S, Zhang J, Wei C, Lu Z, Cai R, Pan D, Zhang H, Liang B, Zhang Z.
    Cancer Chemother Pharmacol; 2020 Jun 28; 85(6):1097-1108. PubMed ID: 32449143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.